Hoshi Iryo-Sanki Co., Ltd. (TYO:7634)
4,700.00
0.00 (0.00%)
Aug 26, 2025, 10:47 AM JST
Hoshi Iryo-Sanki Revenue
Hoshi Iryo-Sanki had revenue of 3.74B JPY in the quarter ending June 30, 2025, with 3.92% growth. This brings the company's revenue in the last twelve months to 15.24B, up 1.39% year-over-year. In the fiscal year ending March 31, 2025, Hoshi Iryo-Sanki had annual revenue of 15.10B with 2.19% growth.
Revenue (ttm)
15.24B
Revenue Growth
+1.39%
P/S Ratio
0.96
Revenue / Employee
30.49M
Employees
500
Market Cap
14.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 15.10B | 324.00M | 2.19% |
Mar 31, 2024 | 14.78B | 999.00M | 7.25% |
Mar 31, 2023 | 13.78B | 1.01B | 7.89% |
Mar 31, 2022 | 12.77B | 962.00M | 8.15% |
Mar 31, 2021 | 11.81B | 931.00M | 8.56% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
HOYA Corporation | 876.09B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |